|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 226 out of 226 for Epm2a

<< First    < Previous  |  Next >    Last >>
0.017s

Categories

Hits by Category

Hits by Strain

Type Details Score
Publication  
First Author: García-Gimeno MA
Year: 2018
Journal: Cells
Title: Lafora Disease: A Ubiquitination-Related Pathology.
Volume: 7
Issue: 8
Publication
First Author: Mittal S
Year: 2007
Journal: Hum Mol Genet
Title: Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment.
Volume: 16
Issue: 7
Pages: 753-62
Protein Domain
Type: Family
Description: Laforin (encoded by the EPM2A gene) is a protein phosphatase and one of the two proteins (the other one is malin, a E3-ubiquitin ligase) that is defective in Lafora disease (LD), a progressive form of inherited epilepsy associated with widespread neurodegeneration and the formation of polyglucosan bodies in the neurons []. Laforin and malin form a functional complex, in which laforin could recognize and recruit putative substrates to be ubiquitinated by malin for degradation. The Laforin-malin complex regulates glycogen synthesis through targeting R5/PTG (Protein Targeting to Glycogen) for inactivation, most probably by proteolysis. Moreover, the Laforin-Malin complex is also involved in different pathways, such as intracellular protein degradation, oxidative stress, and the endoplasmic reticulum unfolded protein response []. It contains a carbohydrate binding module (CBM) at the N terminus and a dual specificity phosphatase domain (DSP) at the C terminus. The structure of Laforin has been revealed [].
Publication
First Author: Wang W
Year: 2006
Journal: Biochem Biophys Res Commun
Title: Relationship between glycogen accumulation and the laforin dual specificity phosphatase.
Volume: 350
Issue: 3
Pages: 588-92
Publication
First Author: Brewer MK
Year: 2019
Journal: Cell Metab
Title: Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.
Volume: 30
Issue: 4
Pages: 689-705.e6
Publication
First Author: Pei L
Year: 2011
Journal: Nat Med
Title: Thyroid hormone receptor repression is linked to type I pneumocyte-associated respiratory distress syndrome.
Volume: 17
Issue: 11
Pages: 1466-72
Publication
First Author: Worby CA
Year: 2006
Journal: J Biol Chem
Title: Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates.
Volume: 281
Issue: 41
Pages: 30412-8
Publication
First Author: Wang J
Year: 2002
Journal: J Biol Chem
Title: A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen.
Volume: 277
Issue: 4
Pages: 2377-80
Publication
First Author: Christiansen C
Year: 2009
Journal: FEBS J
Title: The carbohydrate-binding module family 20--diversity, structure, and function.
Volume: 276
Issue: 18
Pages: 5006-29
Protein Domain
Type: Domain
Description: Laforin, encoded by the EPM2A gene, is a dual-specificity phosphatase that dephosphorylates complex carbohydrates. Mutations in the gene encoding laforin result in Lafora disease, a fatal autosomal recessive neurodegenerative disorder characterised by the presence of intracellular deposits of insoluble, abnormally branched, glycogen-like polymers, known as Lafora bodies, in neurons, muscle, liver, and other tissues. The molecular basis for the formation of these Lafora bodies is unknown. Laforin is one of the only phosphatases that contains a carbohydrate-binding module [].Laforin is a protein containing a dual-specificity protein phosphatase catalytic domain in the C terminus and a carbohydrate-binding domain in the N terminus [].The CBM20 domain is found in a large number of starch degrading enzymes including alpha-amylase, beta-amylase, glucoamylase, and CGTase (cyclodextrin glucanotransferase). CBM20 is also present in proteins that have a regulatory role in starch metabolism in plants (e.g. alpha-amylase) or glycogen metabolism in mammals (e.g. laforin). CBM20 folds as an antiparallel β-barrel structure with two starch binding sites. These two sites are thought to differ functionally with site 1 acting as the initial starch recognition site and site 2 involved in the specific recognition of appropriate regions of starch [].
Publication
First Author: DePaoli-Roach AA
Year: 2010
Journal: J Biol Chem
Title: Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.
Volume: 285
Issue: 33
Pages: 25372-81
Publication
First Author: Augé E
Year: 2018
Journal: Glia
Title: Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease.
Volume: 66
Issue: 10
Pages: 2094-2107
Publication
First Author: Sánchez-Elexpuru G
Year: 2017
Journal: Neuroreport
Title: 4-Phenylbutyric acid and metformin decrease sensitivity to pentylenetetrazol-induced seizures in a malin knockout model of Lafora disease.
Volume: 28
Issue: 5
Pages: 268-271
Publication
First Author: Berthier A
Year: 2016
Journal: Mol Neurobiol
Title: Pharmacological Interventions to Ameliorate Neuropathological Symptoms in a Mouse Model of Lafora Disease.
Volume: 53
Issue: 2
Pages: 1296-309
Publication
First Author: Solaz-Fuster MC
Year: 2008
Journal: Hum Mol Genet
Title: Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.
Volume: 17
Issue: 5
Pages: 667-78
Publication
First Author: Nitschke S
Year: 2022
Journal: Brain
Title: Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.
Volume: 145
Issue: 7
Pages: 2361-2377
Protein
Organism: Mus musculus/domesticus
Length: 330  
Fragment?: false
Publication
First Author: Bulfone A
Year: 2005
Journal: J Neurosci
Title: Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes.
Volume: 25
Issue: 33
Pages: 7586-600
Publication  
First Author: Tamplin OJ
Year: 2008
Journal: BMC Genomics
Title: Microarray analysis of Foxa2 mutant mouse embryos reveals novel gene expression and inductive roles for the gastrula organizer and its derivatives.
Volume: 9
Pages: 511
Publication
First Author: Okazaki N
Year: 2003
Journal: DNA Res
Title: Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.
Volume: 10
Issue: 1
Pages: 35-48
Publication        
First Author: Mouse Genome Informatics Scientific Curators
Year: 2002
Title: FANTOM2 Data Curation in Mouse Genome Informatics
Publication  
First Author: Bedogni F
Year: 2021
Journal: Front Mol Neurosci
Title: Cell-Type-Specific Gene Expression in Developing Mouse Neocortex: Intermediate Progenitors Implicated in Axon Development.
Volume: 14
Pages: 686034
Publication
First Author: Okazaki Y
Year: 2002
Journal: Nature
Title: Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs.
Volume: 420
Issue: 6915
Pages: 563-73
Publication
First Author: Kawai J
Year: 2001
Journal: Nature
Title: Functional annotation of a full-length mouse cDNA collection.
Volume: 409
Issue: 6821
Pages: 685-90
Publication        
First Author: MGD Nomenclature Committee
Year: 1995
Title: Nomenclature Committee Use
Publication      
First Author: MGI Genome Annotation Group and UniGene Staff
Year: 2015
Journal: Database Download
Title: MGI-UniGene Interconnection Effort